Brain pseudoatrophy and mental regression on valproate and a mitochondrial DNA mutation

Neurology. 2006 Nov 14;67(9):1715-7. doi: 10.1212/01.wnl.0000242882.58086.9a.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anticonvulsants / adverse effects
  • Atrophy / chemically induced*
  • Atrophy / genetics
  • Atrophy / pathology
  • Brain / drug effects*
  • Brain / pathology
  • Brain / physiopathology
  • Child
  • Cognition Disorders / chemically induced*
  • Cognition Disorders / genetics
  • Cognition Disorders / physiopathology
  • DNA Mutational Analysis
  • DNA, Mitochondrial / genetics*
  • Developmental Disabilities / chemically induced*
  • Developmental Disabilities / genetics
  • Developmental Disabilities / physiopathology
  • Electroencephalography
  • Epilepsy / drug therapy
  • Epilepsy / genetics
  • Epilepsy / physiopathology
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Intelligence / drug effects
  • Intelligence / genetics
  • Intelligence Tests
  • Magnetic Resonance Imaging
  • Male
  • Mutation / genetics
  • Polymorphism, Genetic / genetics
  • Valproic Acid / adverse effects*

Substances

  • Anticonvulsants
  • DNA, Mitochondrial
  • Valproic Acid